公开(公告)号：DE10151764A1

公开(公告)日：2003-05-08

申请号：DE10151764

申请日：2001-10-19

Applicant: BASF AG

Inventor： KRAEMER KLAUS ,  ROTH ERICH

IPC: A23L33/10 ,  A23L33/175 ,  A61K31/195 ,  A61K31/198 ,  A61K31/385 ,  A61P1/04 ,  A61P1/10 ,  A61P1/12 ,  A61P1/16 ,  A61P1/18 ,  A61P3/02 ,  A61P29/00 ,  A61P31/00 ,  A61P31/04 ,  A61P31/18 ,  A61P37/04 ,  A61P43/00 ,  A23L1/30 ,  A23L1/305

Abstract: The invention relates to the use of at least one liponic acid, a physiologically acceptable derivative or salt thereof and at least one glutamine, a physiologically acceptable derivative or salt thereof, as a food adjunct, in functional foods and for therapeutic purposes, namely the treatment of particular disturbances caused by a glutathione deficiency. Means with an appropriate combination of active ingredients and means in the form of commercial packages, with appropriate combination preparations or single preparations for combined use are disclosed.

公开(公告)号：DE10125901A1

公开(公告)日：2002-12-05

申请号：DE10125901

申请日：2001-05-28

Applicant: BASF AG

Inventor： KRAEMER KLAUS ,  GRUNE TILMAN ,  SIEMS WERNER G

IPC: A23L7/126 ,  A23L33/175 ,  A61P43/00 ,  A23L1/30 ,  A61K31/385

Abstract: The invention relates to the use of at least one lipoic acid, a physiologically acceptable derivative or salt thereof, at least one carnitine, a physiologically acceptable derivative or salt thereof, and at least one creatine, and a physiologically acceptable derivative or salt thereof, for supplementing food, in functional foods and for therapeutic purposes, i.e. especially for treating certain disorders associated with oxidative processes. The invention also relates to agents having a corresponding combination of active ingredients, and agents in the form of commercial packages having corresponding combination preparations or monopreparations for combined use.

公开(公告)号：DE10064818A1

公开(公告)日：2002-06-27

申请号：DE10064818

申请日：2000-12-22

Applicant: BASF AG

Inventor： KRAEMER KLAUS ,  JAEDICKE HAGEN ,  JENTZSCH AXEL

IPC: A61K8/49 ,  A61K8/00 ,  A61K8/02 ,  A61K8/06 ,  A61K8/14 ,  A61K31/353 ,  A61P17/00 ,  A61P17/16 ,  A61Q1/00 ,  A61Q1/02 ,  A61Q1/04 ,  A61Q1/06 ,  A61Q5/00 ,  A61Q5/02 ,  A61Q5/06 ,  A61Q5/12 ,  A61Q15/00 ,  A61Q17/04 ,  A61Q19/00 ,  A61Q19/08 ,  A61Q19/10 ,  A61K7/00 ,  A61K7/48

公开(公告)号：AU8405701A

公开(公告)日：2002-03-26

申请号：AU8405701

申请日：2001-09-11

Applicant: BASF AG

Inventor： HASSELWANDER OLIVER ,  KRAEMER KLAUS ,  BALDENIUS KAI-UWE ,  KLATT MARTIN JOCHEN ,  SCHWEIKERT LONI

IPC: A61K31/381 ,  A23L1/30 ,  A61K31/00 ,  A61K31/202 ,  A61K31/385 ,  A61P3/10 ,  A61P9/10 ,  A61P13/12 ,  A61P25/02 ,  A61P27/02

Abstract: The present invention relates to the use of lipoic acid, a physiologically acceptable derivative or salt thereof and one compound of the formula I H3C-(CH2)n1-(CH=CH)n3-(CH2)n2-COOH I in which n1, n2 have, independently of one another, the value of an integer from 3 to 9, n3 has the value of an integer from 2 to 6, and the number of carbon atoms is 18, 20 or 22, a physiologically acceptable derivative or salt thereof, for nutritional supplementation, in functional foods and for therapeutic purposes in the treatment of diabetic disorders. Compositions having a corresponding active ingredient combination, and compositions in the form of commercial packs with corresponding combination products or single-drug products for combined use are also described.

公开(公告)号：DE10045059A1

公开(公告)日：2002-03-21

申请号：DE10045059

申请日：2000-09-12

Applicant: BASF AG

Inventor： HASSELWANDER OLIVER ,  KRAEMER KLAUS ,  BALDENIUS KAI-UWE ,  KLATT MARTIN JOCHEN ,  SCHWEIKERT LONI

IPC: A61K31/381 ,  A23L1/30 ,  A61K31/00 ,  A61K31/202 ,  A61K31/385 ,  A61P3/10 ,  A61P9/10 ,  A61P13/12 ,  A61P25/02 ,  A61P27/02 ,  A61K31/20

Abstract: The invention relates to the use of lipoic acids, or a physiologically acceptable derivative or salt thereof, and a compound of formula (I): H3C-(CH2)n1-(CH=CH)n3-(CH2)n2-COOH - wherein n1 and n2 independently have the value of a whole number from 3 to 9, n3 has the value of a whole number from 2 to 6, and the number of carbon atoms amounts to 18, 20 or 22 - or a physiologically acceptable derivative or salt thereof, as food supplements, in functional foods and for therapeutic purposes in the treatment of diabetic disorders. The invention also relates to agents having a corresponding active ingredient combination and to agents in the form of commercial packs having corresponding combination preparations or monopreparations for combined use.

公开(公告)号：DE19936831A1

公开(公告)日：2001-02-08

申请号：DE19936831

申请日：1999-08-05

Applicant: BASF AG

Inventor： KRAEMER KLAUS ,  GRUNE TILMANN ,  SIEMS WERNER

IPC: A23K20/158 ,  A23K20/174 ,  A23K50/75 ,  A23L33/00 ,  A23L33/12 ,  A61K31/202 ,  A61K31/355 ,  A61K31/353

Abstract: The invention relates to the use of n-3-PUFA and/or vitamin E for reducing the formation of cholesterol oxides.

公开(公告)号：DE19927574A1

公开(公告)日：2000-12-21

申请号：DE19927574

申请日：1999-06-17

Applicant: BASF AG

Inventor： RADEMACHER WILHELM ,  KRAEMER KLAUS ,  SCHWEDEN JUERGEN ,  HERBERS KARIN

IPC: A01H5/00 ,  A23K1/14 ,  A23L1/30 ,  A61K8/96 ,  A61K8/97 ,  A61K36/00 ,  A61K36/18 ,  A61K36/23 ,  A61K36/48 ,  A61K36/73 ,  A61K36/75 ,  A61K36/81 ,  A61K36/896 ,  A61K36/899 ,  A61P1/14 ,  A61P3/06 ,  A61P29/00 ,  A61P35/00 ,  A61P39/06 ,  A61P43/00 ,  A61Q19/00 ,  C12N5/10 ,  C12N9/02 ,  C12N15/09 ,  C12N15/29 ,  C12N15/53 ,  C12N15/82 ,  A61K7/00

Abstract: Increasing the content of flavonoids and phenolic metabolites (I) in plants by producing plants with reduced activity of flavanone-3-hydroxylase (F3H) using genetic engineering methods, is new. An Independent claim is also included for plants with increased (I) content produced this way.